Nabil Saidah
Dr. Nabil Saidah is an esteemed Egyptian researcher and the Director of the Neuroendocrine Research Unit at the Montreal Clinical Research Institute. He is widely recognized for his groundbreaking contributions to cardiovascular health, particularly in understanding cholesterol regulation and the body's lipid metabolism. His research has led to the development of innovative cholesterol-lowering medications, significantly impacting the prevention of heart disease. With over 820 published scientific papers and more than 71,000 citations of his work, Dr. Saidah has established himself as a leading figure in medical research and has recently been awarded the 'Nobles of Arabs 2025' prize in the field of medicine.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United Arab Emirates | 3 | 8.33 | 0.28% | +0% | 9,890,400 | 27,992 | $430,000 | 1,217$ |
| Totals | 3 | 9,890,400 | 27,992 | $430,000 | 1,217$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United Arab Emirates:
Dr. Nabil Saidah won the 'Nobles of Arabs 2025' award for his contributions to heart health and cholesterol management.
9
United Arab Emirates:
Dr. Nabil Saidah is honored for his contributions in the field of medicine.
8
United Arab Emirates:
Nabil Saidah is honored for his achievements in the field of medicine as part of the 'Arab Talents 2025'.
8
United Arab Emirates:
Dr. Nabil Saidah is recognized for his pioneering contributions to heart health and cholesterol regulation.
9